BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 11051249)

  • 1. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.
    Tornillo L; Carafa V; Richter J; Sauter G; Moch H; Minola E; Gambacorta M; Bianchi L; Vecchione R; Terracciano LM
    J Pathol; 2000 Nov; 192(3):307-12. PubMed ID: 11054713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization.
    Sakakura C; Hagiwara A; Taniguchi H; Yamaguchi T; Yamagishi H; Takahashi T; Koyama K; Nakamura Y; Abe T; Inazawa J
    Br J Cancer; 1999 Aug; 80(12):2034-9. PubMed ID: 10471057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
    Guan XY; Fang Y; Sham JS; Kwong DL; Zhang Y; Liang Q; Li H; Zhou H; Trent JM
    Genes Chromosomes Cancer; 2000 Oct; 29(2):110-6. PubMed ID: 10959090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
    Wong N; Lai P; Lee SW; Fan S; Pang E; Liew CT; Sheng Z; Lau JW; Johnson PJ
    Am J Pathol; 1999 Jan; 154(1):37-43. PubMed ID: 9916916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    SzymaƱska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
    Teramoto T; Satonaka K; Kitazawa S; Fujimori T; Hayashi K; Maeda S
    Cancer Res; 1994 Jan; 54(1):231-5. PubMed ID: 8261444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
    Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
    Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China.
    Scorsone KA; Zhou YZ; Butel JS; Slagle BL
    Cancer Res; 1992 Mar; 52(6):1635-8. PubMed ID: 1311638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
    Kusano N; Shiraishi K; Kubo K; Oga A; Okita K; Sasaki K
    Hepatology; 1999 Jun; 29(6):1858-62. PubMed ID: 10347130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
    Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.